![Sharon Longhurst](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sharon Longhurst
Directeur/Membre du Conseil chez
ELICERA THERAPEUTICS AB
Profil
Dr. Sharon Longhurst is an Independent Director at Elicera Therapeutics AB and an Independent Director at Idogen AB. She is on the Board of Directors at Elicera Therapeutics AB and Idogen AB. Dr. Longhurst was previously employed as a Vice President-Development by Gadeta BV and a Head-Chemistry, Manufacturing & Control by Mendus AB. She received her undergraduate degree from the University of Surrey and a doctorate degree from the University of Warwick.
Postes actifs de Sharon Longhurst
| Sociétés | Poste | Début |
|---|---|---|
| ELICERA THERAPEUTICS AB | Directeur/Membre du Conseil | 01/01/2024 |
Idogen AB
 Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Directeur/Membre du Conseil | 12/05/2020 |
Anciens postes connus de Sharon Longhurst
| Sociétés | Poste | Fin |
|---|---|---|
Gadeta BV
 Gadeta BV BiotechnologyHealth Technology Conducts research and develops medicines & treatment methods for cancer | Corporate Officer/Principal | 01/08/2023 |
| MENDUS AB | Corporate Officer/Principal | - |
Formation de Sharon Longhurst
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
23
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mendus AB
 Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Health Technology |
Gadeta BV
Gadeta BV BiotechnologyHealth Technology Conducts research and develops medicines & treatment methods for cancer | Health Technology |
Elicera Therapeutics AB
 Elicera Therapeutics AB BiotechnologyHealth Technology Develops and trades cell and gene therapies in immune-oncology | Health Technology |
